Meyer Children's Hospital IRCCS
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Meyer Children's Hospital IRCCS sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Meyer Children's Hospital IRCCS: 6 sponsored US clinical trials, 5 recruiting.
Meyer Children's Hospital IRCCS sponsors 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. The most-studied condition in this pipeline is Eosinophilic Fasciitis, with 1 trials.
Upper-quartile sponsor footprint
Meyer Children's Hospital IRCCS sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
SLIT ABS: Study on Patients With Autoimmune Podocytopathy
NCT07516964
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
NCT07348263
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993
ECD-Score: a Study on Erdheim-Chester Disease
NCT07454343
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
NCT06273748
Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
NCT06276036
Therapeutic Areas
What is open in the Meyer Children's Hospital IRCCS pipeline
5 recruiting of 6 indexed (83% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Eosinophilic Fasciitis (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Meyer Children's Hospital IRCCS: open-pipeline peers nationwide
Peers matched on 6 registered trials and 83% open enrollment, not the therapeutic-area sidebar.
Meyer Children's Hospital IRCCS sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 83% open enrollment (± trial volume)
- Centessa Pharmaceuticals (UK) Limited · 83% recruiting · 6 trials
- SystImmune · 83% recruiting · 6 trials
- Tyra Biosciences · 83% recruiting · 6 trials
- Johnson & Johnson Enterprise Innovation · 86% recruiting · 7 trials
Related
What to do with this Meyer Children's Hospital IRCCS page
6 registered trials is a research-attention snapshot, not an endorsement of Meyer Children's Hospital IRCCS or any single study.
- 5 of Meyer Children's Hospital IRCCS's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Eosinophilic Fasciitis is the condition Meyer Children's Hospital IRCCS studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eosinophilic Fasciitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Meyer Children's Hospital IRCCS pipeline card: 6 registered trials from official public datasets.Report a data error.